Resolution Criteria

The White House stated that President Trump is using a preventative skin treatment prescribed by the White House Doctor, with the treatment lasting one week and redness expected to last a few weeks. This market resolves YES if, by end of day March 31, 2026, the White House, Trump's physician, or credible medical sources publicly disclose the specific medical condition or treatment being used on Trump's neck. This includes any official statement naming the condition (e.g., shingles, dermatitis, etc.) or the specific medication/cream being applied. The market will also resolve YES if there is clear and convincing reporting in the mainstream press that answers those questions, even if such reporting is not confirmed by official sources. The market resolves NO if no such disclosure occurs by the deadline.

Note that this market will resolve YES based on official statements even if the official statements are dubious, as long as they are not clearly designed to obfuscate and/or “troll”; that is, the source of the information must be trying to express the information to the public, even if the information may be false.

Background

A significant rash-like injury was noticed on the right side of Trump's neck at a Medal of Honor ceremony on Monday, with press photos showing what looks like a prominent reddish wound or scabbing below his right ear. Photos suggest the redness first emerged during Trump's trip to Corpus Christi, Texas on Friday, but the irritation was far more noticeable on Monday, with the skin behind his right ear looking scabbed and flaking. Common explanations could include contact dermatitis from shaving products or cologne, razor burn, allergic reactions, heat rash, or irritation from clothing, though viral infections such as shingles can also produce localized rashes.

Considerations

Netizens have been speculating wildly, with many suggesting it could be shingles, an infection caused by the same virus that causes chickenpox that typically causes red, blistered rashes. The White House has provided minimal detail beyond stating it is a "very common cream" for "preventative skin treatment," deliberately avoiding naming the specific condition or medication.

This description was composed with AI.

• Update 2026-03-02 (PST) (AI summary of creator comment): The market will resolve based on whether information is disclosed by the end of March 2026, USA Eastern Time (not by the market close date of April 2, 2026).